Minerva Neurosciences, Inc. (NERV)
NASDAQ: NERV · Real-Time Price · USD
4.540
+0.120 (2.71%)
At close: Aug 18, 2026, 4:00 PM EDT
4.600
+0.060 (1.32%)
After-hours: Aug 18, 2026, 4:37 PM EDT
Minerva Neurosciences Market Cap
Minerva Neurosciences has a market cap or net worth of $216.77 million as of August 18, 2026. Its market cap has increased by 1,280.73% in one year.
Market Cap
216.77M
Enterprise Value
201.51M
1-Year Change
1,280.73%
Ranking
Category
Stock Price
$4.54
ChartMarket Cap Chart
Since July 1, 2014, Minerva Neurosciences's market cap has increased from $110.60M to $216.77M, an increase of 96.00%. That is a compound annual growth rate of 5.70%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 18, 2026 | 216.77M | 671.44% |
| Dec 31, 2025 | 28.10M | 81.29% |
| Dec 31, 2024 | 15.50M | -63.95% |
| Dec 29, 2023 | 43.00M | 405.88% |
| Dec 30, 2022 | 8.50M | -75.15% |
| Dec 31, 2021 | 34.20M | -65.77% |
| Dec 31, 2020 | 99.90M | -64.00% |
| Dec 31, 2019 | 277.50M | 5.92% |
| Dec 31, 2018 | 262.00M | 11.92% |
| Dec 29, 2017 | 234.10M | -42.76% |
| Dec 30, 2016 | 409.00M | 172.49% |
| Dec 31, 2015 | 150.10M | 35.23% |
| Dec 31, 2014 | 111.00M | 0.36% |
| Jul 1, 2014 | 110.60M | - |
View and export this data all the way back to 2014. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Cellectis | 228.78M |
| Compugen | 228.29M |
| NovaBridge Biosciences | 226.67M |
| AN2 Therapeutics | 226.04M |
| Atrium Therapeutics | 219.64M |
| Immunic | 219.13M |
| Alector | 218.85M |
| Tonix Pharmaceuticals Holding | 217.99M |